Article
High Estrogen Receptor β Expression Is Prognostic among Adjuvant Chemotherapy-Treated Patients-Results from a Population-Based Breast Cancer Cohort.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Feb 2017
Elebro Karin, Borgquist Signe, Rosendahl Ann H, Markkula Andrea, Simonsson Maria, Jirström Karin, Rose Carsten, Ingvar Christian, Jernström Helena
Abstract excerpt
PURPOSE: Isoform-specific tumor estrogen receptor β (ERβ) expression may hold prognostic information in breast cancer, especially among endocrine-treated breast cancer patients. The study's purpose was to evaluate ERβ isoform 1 (ERβ1) expression in relation to tumor characteristics, ESR2 genotypes, and prognosis in different treatment groups. EXPERIMENTAL DESIGN: A population-based prospective cohort of 1,026...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
